Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of May 2025. The report specifically details a transaction in the company's own shares executed under its share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide comprehensive financial statements such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the share repurchase activity:
- Date of Purchase: May 02, 2025
- Shares Purchased: 85,611
- Highest Price Paid: 398.20 pence per share
- Lowest Price Paid: 387.20 pence per share
- Volume Weighted Average Price: 394.66 pence per share
Material Changes
Following the settlement of the share purchase, the Company's registered share capital stands at 9,020,046,372 ordinary shares of £0.01 each. Of these, 4,080,205 are held as treasury shares. Consequently, the number of ordinary shares with voting rights is 9,015,966,167.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operational outlook, or discussion of risks and contingencies. It is a routine disclosure of a share buyback transaction in compliance with the Market Abuse Regulation (Regulation (EU) No 596/2014).
Key Facts for Investor Verification
- Verify the total number of voting shares (9,015,966,167) for compliance with FCA Disclosure Guidance and Transparency Rules.
- Confirm the remaining capacity under the Buyback Programme announced on March 28, 2025.
- Review the full breakdown of individual trades available via the provided London Stock Exchange link.